By Glenn Sabin This is the second post in a series of three.Why Your Blog Strategy is So ImportantHow to maximize readership of your blog content In my last post I discussed why it’s so important for providers of integrative medicine services to create a smart, sustainable blog strategy. Surprisingly, the majority of integrative centers today do not maintain a blog. And those who do rarely have a proper, long term plan to
By Glenn Sabin This is the first post in a series of threeCreating a Sustainable Blog Strategy for Your Integrative CenterHow to Maximize Readership of your Blog Content Each week FON studies a number of websites for clients of various types and sizes that provide integrative medicine services. We focus on four primary areas: design, functionality, messaging and content strategy. Over the next few weeks I will be blogging about content
By Glenn Sabin If your center provides conventional or integrative oncology care with medical oncologists on staff, or otherwise offers supportive cancer care services across a spectrum of interventions–i.e., nutritional support, exercise physiology, mindfulness-based stress reduction techniques, acupuncture and psychosocial counseling–you should attend at the Eighth International Conference of the Society for Integrative Oncology (SIO), November 10-12, 2011 at the InterContinental Hotel and Conference Center in Cleveland, Ohio. This year’s CME event
By Glenn Sabin Photo on left by Stephen Webster, as seen in the Atlantic article: The Triumph of New Age Medicine (Note: For those of you who missed David H. Freedman’s piece in the July 2011 edition of the Atlantic, I urge you to read it and the debate that followed. This post was originally intended as a response to appear on the Atlantic’s Web site, but that debate has since closed.) I have employed an
By Glenn Sabin Does your center have a content creation and distribution strategy? Consumers interested in a patient-centered approach to their healthcare spend a lot of time learning about preventive medicine and general wellness. When they or a family member face a health challenge, they are quick to consult the Web for their health information needs. So when it comes to evidence-based integrative medicine, your center or clinic has a
By Glenn Sabin Most integrative medicine clinics and centers do a poor job communicating to their patients and prospective patients about the evidence supporting their clinical recommendations and interventions. While it’s accurate to say that the science base for integrative medicine is a mere fraction of that for conventional interventions and pharmaceuticals, the amount of quality research and positive outcomes is growing steadily. Now is the time for integrative centers to
By Glenn Sabin Integrative oncology research and discussions will be featured prominently during the ASCO 2011 Annual Meeting this weekend in Chicago, with several presenters among Society for Integrative Oncology leadership. After many years advocating for integrative oncology research to be presented at the meeting, I am pleased to note that evidence-based complementary interventions are becoming part of the vanguard for oncology care, driven be consumer demand and a growing science base. The
By Glenn Sabin House Resolution 3590, aka the Patient Protection and Affordable Care Act (PPACA), and House Resolution 4872, aka the Health Care and Education Reconciliation Act, combined to create the monumental healthcare reform law of 2010. Executive Order 13544, a requirement under H.R. 3590, established the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health. Over time this executive order may profoundly change our healthcare delivery model. In
By Glenn Sabin In conventional medicine, personalized medicine is all the buzz. Although a decade after decoding the human genome has not yet resulted in the panacea leading to game-changing cures that were once thought possible, huge strides are being made in growing the knowledge base of genomics, as well as molecular immunology and biotechnology. Over 2000 molecular diagnostic and genetic tests are available today with many novel targeted therapies